0
Clinical Trial Tier 1 Sign in to save

Microplastics in neonates: an overlooked cost of parenteral nutrition

AI summary Read the abstract

Researchers detected microplastics in neonatal blood at levels that increased with parenteral nutrition duration, with larger particles over 60 µm found exclusively in long-term recipients — suggesting that intravenous nutrition delivery systems may be an underrecognized iatrogenic source of microplastic exposure in vulnerable newborns.

Models
Study Type Human

Introduction: Microplastics (MPs) are emerging contaminants that raise concerns due to their potential health effects on vulnerable neonates who may be exposed to medical devices. Methods: This prospective study investigated the presence of MPs in neonatal blood in relation to parenteral nutrition (PN) duration. A total of 12 neonates were categorized into long-term (>14 days), short-term (3-7 days), and non-exposed control groups. MPs were analyzed using confocal micro-Raman spectroscopy. Results: < 0.05), demonstrating a dose-response relationship with PN duration. Notably, larger MPs (>60 μm) were found exclusively in the long-term group. Discussion: These preliminary findings, derived from a small sample cohort, suggest that the PN system may serve as a potential iatrogenic source of MPs for neonates. Clinical trial registration: NCT07326761.

More Papers Like This

Article Tier 2

An Ex Vivo Study Examining Migration of Microplastics from an Infused Neonatal Parenteral Nutrition Circuit

AI summary Read the abstract

This ex vivo study quantified microplastics released from neonatal parenteral nutrition infusion circuits, finding that plastic particles migrate from the tubing and connectors into infused solutions, raising concerns about iatrogenic microplastic exposure in vulnerable neonatal patients.

Article Tier 2

Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.

AI summary Read the abstract

This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.

Article Tier 2

Identification and quantification of micro–nano-plastics in polypropylene-bottled injections

AI summary Read the abstract

Researchers examined 16 batches of intravenous (IV) fluids packaged in polypropylene plastic bottles and found microplastic and nanoplastic particles in all of them, with concentrations reaching up to 10 million particles per milliliter. This is the first study to confirm that patients receiving IV infusions are being directly exposed to microplastics entering their bloodstream, though whether this causes harm remains to be studied.

Article Tier 2

Is intravenous infusion an unrecognized route for internal microplastic human exposure? A general assessment

AI summary Read the abstract

This study discovered that microplastics are present in intravenous (IV) infusion products used in hospitals, identifying a previously unrecognized route of microplastic exposure that bypasses the body's natural barriers. Standard IV filters removed some but not all of the plastic particles. This finding is important because IV-delivered microplastics go directly into the bloodstream, potentially posing a greater risk than microplastics that are eaten or inhaled.

Article Tier 2

Hidden hazards: microplastics in intravenous admixtures and their path into the body

AI summary Read the abstract

This study investigated microplastic contamination in intravenous (IV) fluid bags used in hospitals, finding that prolonged storage in plastic containers leads to microplastic particles leaching into the solution. This means patients receiving IV treatments may be exposed to microplastics that enter the bloodstream directly, bypassing the body's natural barriers. The findings highlight an overlooked route of microplastic exposure in medical settings that needs further investigation.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper